Skip to main content

Table 5 RT + supplement or dietary control studies

From: Resistance Training and Weight Loss in Older Adults: A Scoping Review

Study

Exercise protocol

WL-related outcome(s)

Feasibility/tolerability

Avila et al. [28]

Frequency: 3x/wk for 10 weeks

Modality: selectorized resistance exercise machines (six upper and lower body; 4 sets × 8–12 repetitions) + stretching

Significant reductions relative to baseline were observed in BM (− 3.3 + 0.8 kg, p < 0.001) and FM (− 4.1 + 0.9 kg, p < 0.001) in the DASH + RT group, while significant reductions in BM were observed in the DASH-only group (− 1.7 + 0.9 kg, p = 0.044). Results support existing knowledge that exercise + diet approaches to WL are generally more effective than diet-only approaches

Dropouts: 1 (96% adherence)

AEs: 1 × minor hip extensor strain

Tolerability: NR

Feasibility: NR

Aguiar et al. [18]

Frequency: 3x/wk for 12 weeks

Medication: Creatine monohydrate (5.0 g/day vs. placebo)

WL outcome measure: Δ body mass, Δ %BF using DEXA

No change in BM or %BF (via DEXA) observed in either group (CRP vs. placebo) relative to baseline. CRP group gained significantly more (p < 0.05) FFM (+ 3.2%) and muscle mass (+ 2.8%) than the placebo group over the course of the study. Results suggest creatine phosphate supplementation may be an effective dietary adjunct for older women participating in a structured RT program

Dropouts / AEs: see Table 2

Tolerability: CR supplementation appears to increase tolerable volume of RT

Feasibility: see Table 2

Beavers et al. [29]

Frequency: 4x/wk (2 × upper body, 2 × lower body) for 18 months

Modality: eight selectorized resistance exercise machines (3 sets of 10–12 repetitions)

Total BM loss was greatest when WL was combined with exercise (WL: − 5.7 + 0.7 kg, WL + AT: − 8.5 + 0.7 kg, WL + RT: − 8.7 + 0.7 kg; p < 0.01). LM loss was greatest in WL + AT (− 1.6 + 0.3 kg, − 3.1%) compared with WL + RT (− 0.8 + 0.3 kg, − 1.5%) or WL (− 1.0 + 0.3 kg; − 2.0%); both p = 0.02. Results confirm and existing literature WL + RT is preferable to WL + AT with respect to exercise aimed at improving body composition in obese and overweight older adults

Dropouts: 14 (17%)

AEs: 2 × dropout due to medical complication

Tolerability: NR

Feasibility: NR

Brochu et al. [15]

Frequency: 3x/wk for 6 months

Modality: Seven exercises targeting the whole body (leg press, chest press; lateral pull downs; shoulder press; arm curls, triceps extensions). 2–3 sets (15 repetitions, 65% 1RM) per exercise in Phase 1 progressing to 3–4 sets (10–12 repetitions, 75% 1RM) per exercise in Phase 4

Both CR and CR + RT were found to facilitate significant improvements in BM, %FM (via DEXA), and total FM. Results reinforce the complementary role exercise and diet play in healthy weight loss and upper limit of RT-alone to effect body composition

Dropouts: 30 (21.9%)

AEs: 3

Tolerability: NR

Feasibility: NR

Adherence to intervention: see Table 3

Campbell et al. [10]

Frequency: 3x/wk for 16 weeks

Modality: Pneumatic resistance exercise machines targeting the whole body (2–3 sets of 8–12 repetitions per exercise @ approx. 80% 1RM)

RT did not lead to any additional in weight loss or %BF changes compared to the non-exercising control. Results reinforce the complementary role exercise and diet play in healthy weight loss and upper limit of RT-alone to effect body composition

Dropouts: 0

AEs: NR

Tolerability: NR

Feasibility: NR

Shea et al. [34]

Frequency: 3x/wk for 16 weeks

Modality: 2 × pneumatic resistance exercise machines (lower body) + combination of Nautilus resistance machines and dumbbells (upper body). Progression for all exercises was as follows. Week 1: two sets of 8–10 reps at 40–50% of 1RM; Week 2: three sets of 8–10 reps at 50–60% of 1RM; Weeks 3–16: three sets of 8–10 reps at 70% of 1RM

Men who were given pioglitazone lost more visceral abdominal fat than men who were not given pioglitazone (p = 0.007), while women who were given pioglitazone lost less thigh subcutaneous fat (p = 0.002). RT diminished thigh muscle loss in men and women (RT vs. no RT men: p = 0.005, women: p = 0.04). In overweight/obese older men undergoing weight loss, pioglitazone increased visceral fat loss and RT reduced skeletal muscle loss

Dropouts: 7 (8%)

AEs: 0

Tolerability:

Feasibility

Straight et al. [28]

Frequency: 2x/wk for 8 weeks

Modality: Combination of free weights, elastic tubing and ankle weights targeting whole body muscle groups (three sets of 8–12 repetitions per exercise)

Significant reductions observed in BM (–1.0 ± 1.8 kg, p < 0.001), BMI (–0.4 ± 0.8 kg/m2, p < 0.001; via BIA), %FM (–0.5 ± 1.4%, p < 0.001; via BIA), and FM (–0.8 ± 1.6 kg, p < 0.001; via BIA)

Dropouts: 14 (12.8%)

AEs: 1 (strained muscle leading to dropout

Tolerability: potentially enhanced by use of RPE to monitor RT intensity [39]

Feasibility: enhanced by use of portable and inexpensive RT modalities such as ankle weights, elastic tubing

Verreijin et al. [31]

Frequency: 3x/wk for 10 weeks

Modality: Squats, lunges, chest press, shoulder press, biceps curls, triceps extensions, standing rows, step-ups and crunches (2 sets per exercise progressing to 3 sets)

Significant decrease in BM and FM across all groups (p < 0.05; both via ADP), highest in exercise cohorts although the between-group difference was non-significant. There was no significant effect of high protein and exercise on change in FFM and FM, but RT significantly decreased body fat percentage with 0.8% (p = 0.048)

Dropouts: 32 (32%)

Adherence to intervention: mean adherence = 2.8 ± 0.3 times/week

AEs: 1

Tolerability: low considering high dropout rate

Feasibility: low considering degree of exercise supervision and dietary control required

  1. 1RM one-repetition maximum, ADP air-displacement plethysmography, AT aerobic training, BF body fat, BIA bioelectrical impedance analysis, BM body mass, BMI body mass index, CH care home, CR caloric restriction, CRP creatine phosphate supplementation, CT combined training, D drug trial, DASH Dietary Approaches to Stop Hypertension, DEXA dual X-ray absorptiometry, ES effect size, FFM fat-free mass, FM fat mass, H healthy, HRT heavy resistance training, MRT moderate intensity resistance training, NPRT non-periodized resistance training, NR not reported, NPRT non-periodized resistance training, O overweight or obese, P postmenopausal, PRT periodized resistance training, QE quasi-experimental, RCT randomized-controlled trial, RT resistance training, SO sarcopenic obesity, W women only, WL weight loss, WPS wide pyramid system